Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology

Biosensors and Bioelectronics

Volumn 47, Issue , 2013, Pages 92-98

  Liu, Nan ^a   Liang, Wenfa ^a   Ma, Xinhua ^a   Li, Xiaoli ^a   Ning, Baoan ^a   Cheng, Chaonan ^a   Ou, Guorong ^a   Wang, Baogui ^b   Zhang, Juan ^c   Gao, Zhixian ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Median Fluorescent Intensity (MFI); Prostate cancer (PCa); Suspension array; Tumor markers (TMs)

Indexed keywords

FIELD EMISSION SCANNING ELECTRON MICROSCOPES; FLUORESCENT INTENSITY; INDIRECT COMPETITIVE ENZYME- LINKED IMMUNOSORBENT ASSAYS; PROSTATE CANCERS; PROSTATE-SPECIFIC MEMBRANE ANTIGENS; SUSPENSION ARRAY; SUSPENSION ARRAY TECHNOLOGIES; TUMOR MARKERS;

ANTIGENS; BODY FLUIDS; CHEMICAL DETECTION; DIAGNOSIS; DISEASES; FLUORESCENCE; MULTIPLEXING; PHOSPHATASES; STEM CELLS; TUMORS; UROLOGY;

BIOMARKERS;

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE STEM CELL ANTIGEN; TUMOR MARKER;

ACID PHOSPHATASE BLOOD LEVEL; ARTICLE; BIOSENSOR; BIOTECHNOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; COST; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLUORESCENCE; HUMAN; INTERMETHOD COMPARISON; MALE; MOLECULAR STABILITY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SERUM; SURFACE PROPERTY; SUSPENSION ARRAY TECHNOLOGY;

ACID PHOSPHATASE; ANTIBODIES; ANTIGENS, SURFACE; BIOSENSING TECHNIQUES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; MEMBRANE PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876320148     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2013.02.052     Document Type: Article

References (46)

1. Anderson G.P., Moreira S.C., Charles P.T., Medintz I.L., Goldman E.R., Zeinali M., Taitt C.R. Analytical Chemistry 2006, 78:2279-2285.
2. Altekruse, S.F., Kosary, C.L., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Ruhl.J., Howlader, N., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M.P., Lewis, D.R., Cronin, K., Chen, H.S., Feuer, E.J., Stinchcomb, D.G., Edwards, B.K., (Eds.). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. http://seer.cancer.gov/csr/1975_2007).
3. Braeckmans K., De Smedt S.C., Leblans M., Pauwels R., Demeester J. Nature Review Drug Discovery 2002, 1:447-456.
4. Catalona W.J., Smith D.S., Ratliff T.L., Dodds K.M., Coplen D.E., Yuan J.J., Petros J.A., Andriole G.L. New England Journal of Medicine 1991, 324:1156-1161.
5. Chen Y.P., Ren H.L., Liu N., Sai N., Liu X.Y., Liu Z., Liu X., Gao Z.X. Journal of Agricultural and Food Chemistry 2010, 58:8895-8903.
6. Damber J.E., Aus G. Lancet 2008, 371:1710-1721.
7. Dannull J., Diener P.A., Prikler L., Fürstenberger G., Cerny T., Schmid U., Ackermann D.K., Groettrup M. Cancer Research 2000, 60:5522-5528.
8. Gao Z., Liu N., Cao Q., Zhang L., Wang S., Yao W., Chao F. Biosensors and Bioelectronics 2009, 24:1445-1450.
9. Gu Z., Yamashiro J., Kono E., Reiter R.E. Cancer Research 2005, 65:9495-9500.
10. Han K.R., Seligson D.B., Liu X., Horvath S., Shintaku P.I., Thomas G.V., Said J.W., Reiter R.E. Journal of Urology 2004, 171:1117-1121.
11. Hara N., Kasahara T., Kawasaki T., Bilim V., Obara K., Takahashi K., Tomita Y. Clincial Cancer Research 2002, 8:1794-1799.
12. Henry N.L., Hayes D.F. Oncologist 2006, 11:541-552.
13. Henry N.L., Hayes D.F. Molecular Oncology 2012, 6:140-146.
14. Hoffman R.M. New England Journal of Medicine 2011, 365:2013-2019.
15. Horoszewicz J.S., Kawinski E., Murphy G.P. AntiCancer Research 1987, 7:927-935.
16. Kim B.K., Lee J.W., Park P.J., Shin Y.S., Lee W.Y., Lee K.A., Ye S., Hyun H., Kang K.N., Yeo D., Kim Y., Ohn S.Y., Noh D.Y., Kim C.W. Breast Cancer Research 2009, 11:R22.
17. Kim D.J., Sohn Y., Jung J.H., Yoon O.J., Lee H.E., Park J.S. Biosensors and Bioelectronics 2013, 41:621-626.
18. Lam J.S., Yamashiro J., Shintaku I.P., Vessella R.L., Jenkins R.B., Horvath S., Said J.W., Reiter R.E. Clincial Cancer Research 2005, 11:2591-2596.
19. Liu M.Y., Xydakis A.M., Hoogeveen R.C., Jones P.H., Smith E.O., Nelson K.W., Ballantyne C.M. Clinical Chemistry 2005, 51:1102-1109.
20. Liu N., Gao Z., Ma H., Su P., Ma X., Li X., Ou G. Biosensors and Bioelectronics 2013, 41:710-716.
21. Liu N., Su P., Gao Z., Zhu M., Yang Z., Pan X., Fang Y., Chao F. Analytica Chimica Acta 2009, 632:128-134.
22. Long Y., Zhang Z., Yan X., Xing J., Zhang K., Huang J., Zheng J., Li W. Analytica Chimica Acta 2010, 665:63-68.
23. Murphy G.P., Kenny G.M., Ragde H., Wolfert R.L., Boynton A.L., Holmes E.H., Misrock S.L., Bartsch G., Klocker H., Pointner J., Reissigl A., McLeod D.G., Douglas T., Morgan T., Gilbaugh J. Urology 1998, 51:89-97.
24. Ngryen L., Chapdeiaine A., Chevaller S. Clinical Chemistry 1990, 36:1450-1455.
25. Raez J., Blais D.R., Zhang Y., Alvarez-Puebla R.A., Bravo-Vasquez J.P., Pezacki J.P., Fenniri H. Langmuir 2007, 23:6482-6485.
26. Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M.M., Loda M., Witte O.N. Proceedings of the National Academy of Sciences 1998, 95:1735-1740.
27. Rochon Y.P., Horoszewicz J.S., Boynton A.L., Holmes E.H., Barren R.J., Erickson S.J., Kenny G.M., Murphy G.P. Prostate 1994, 25:219-223.
28. Ross S., Spencer S.D., Holcomb I., Tan C., Hongo J., Devaux B., Rangell L., Keller G.A., Schow P., Steeves R.M., Lutz R.J., Frantz G., Hillan K., Peale F., Tobin P., Eberhard D., Rubin M.A., Lasky L.A., Koeppen H. Cancer Research 2002, 62:2546-2553.
29. Saffran D.C., Raitano A.B., Hubert R.S., Witte O.N., Reiter R.E., Jakobovits A. Proceedings of the National Academy of Sciences 2001, 98:2658-2663.
30. Seidman H., Mushinski M.H., Gelb S.K., Silverberg E. Cancer Journal for Clinicians 1985, 35:36-56.
31. Siegel R., Ward E., Brawley O., Jemal A. CA-A Cancer Journal for Clinicians 2011, 61:212-236.
32. Stephan C., Cammann H., Meyer H.A., Lein M., Jung K. Cancer Letter 2007, 249:18-29.
33. Su P., Liu N., Zhu M., Ning B., Liu M., Yang Z., Pan X., Gao Z. Talanta 2011, 85:1160-1165.
34. Veeramani S., Yuan T.C., Chen S.J., Lin F.F., Petersen J.E., Shaheduzzaman S., Srivastava S., MacDonald R.G., Lin M.F. Endocrine-Related Cancer 2005, 12:805-822.
35. Venkatasubbarao S. Trends in Biotechnology 2004, 22:630-637.
36. Wan Y., Deng W., Su Y., Zhu X., Peng C., Hu H., Peng H., Song S., Fan C. Biosensors and Bioelectronics 2011, 30:93-99.
37. Wang Y., Liu N., Ning B., Liu M., Lv Z., Sun Z., Peng Y., Chen C., Li J., Gao Z. Biosensor and Bioelectronics 2012, 34:44-50.
38. Wee K.W., Kang G.Y., Park J., Kang J.Y., Yoon D.S., Park J.H., Kim T.S. Biosensor and Bioelectronics 2005, 20:1932-1938.
39. Wilson R., Cossins A.R., Spiller D.G. Angewandte Chemie International Edition 2006, 45:6104-6117.
40. Wright G.L., Scheilhammer P.F., Brassli D.N., Sieg S.M., Leffeil M.S. Clinical Chemistry 1981, 27:1747-1752.
41. Wulfkuhle J.D., Liotta L.A., Petricoin E.F. Nature Reviews Cancer 2003, 3:267-275.
42. Xiao Z., Adam B.L., Cazares L.H., Clements M.A., Davis J.W., Schellhammer P.F., Dalmasso E.A., Wright G.L. Cancer Research 2001, 61:6029-6033.
43. Yurkovetsky Z.R., Kirkwood J.M., Edington H.D., Marrangoni A.M., Velikokhatnaya L., Winans M.T., Gorelik E., Lokshin A.E. Clincial Cancer Research 2007, 13:2422-2428.
44. Zhang T., He Y., Wei J., Que L. Biosensors and Bioelectronics 2012, 38:382-388.
45. Zhao Y.J., Zhao X.W., Hu J., Li J., Xu W.Y., Gu Z.Z. Angewandte Chemie International Edition 2009, 48:7350-7352.
46. Zhao Y.J., Zhao X.W., Sun C., Li J., Zhu R., Gu Z.Z. Analytical Chemistry 2008, 80:1598-1605.